- Adjuvant Strategies for Patients with HR+/HER2- Early-Stage Breast Cancer
- CDK4/6 Inhibitors in HR+ Metastatic Breast Cancer: Optimizing Treatment Selection
- Clinical Scenarios: HR+ Breast Cancer
- Sequencing Beyond CDK4/6 Inhibitors in HR+HER2- Metastatic Breast Cancer
- New Kids on the Block: Antibody-Drug Conjugates for Breast Cancer
- Live Q&A
OncLive® State of the Science Summit™ Breast Cancer
UW Health Eastpark Medical Center
4621 Eastpark Blvd
Madison, WI 53718
United States
Thursday, September 25, 2025
6:00 PM - 8:45 PM CDT
Complimentary Parking
In-Person Only
Event Co-Chairs
Kari Wisinski, MD
University of Wisconsin Carbone Cancer Center
Lubna N. Chaudhary, MD, MS
Froedtert & the Medical College of Wisconsin Cancer Network
IN PARTNERSHIP WITH
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
2 Commerce Drive
Cranbury, NJ 08512